Covered recipient · General Payments record
MARK O EDWARDS
Allopathic & Osteopathic Physicians Family Medicine
This page merges CMS profile IDs 13098, 7225708 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2018–2019
$1,251.56
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $141.63 | 9 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Shire North American Group Inc | $40.35 | 2 |
| Amgen Inc. | $33.95 | 2 |
| Supernus Pharmaceuticals, Inc. | $16.97 | 1 |
| GlaxoSmithKline, LLC. | $13.87 | 1 |
| Allergan Inc. | $13.08 | 1 |
| Merck Sharp & Dohme Corporation | $12.59 | 1 |
| Amneal Pharmaceuticals LLC | $10.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Allergan Inc. | $13.08 | 04/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670287679 | CMS |
| Amgen Inc. | $14.70 | 01/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662719133 | CMS |
| Amgen Inc. | $19.25 | 02/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662719139 | CMS |
| Amneal Pharmaceuticals LLC | $10.82 | 02/01/2019 | Food and Beverage | Undisputed | 01/23/2026 | 692311429 | CMS |
| GlaxoSmithKline, LLC. | $13.87 | 04/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670206217 | CMS |
| Merck Sharp & Dohme Corporation | $12.59 | 01/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | 695208849 | CMS |
| Shire North American Group Inc | $17.16 | 01/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | 637816885 | CMS |
| Shire North American Group Inc | $23.19 | 02/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 637816887 | CMS |
| Supernus Pharmaceuticals, Inc. | $16.97 | 01/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | 702299835 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
- Merged CMS profile IDs
- 13098, 7225708
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.